Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

Resono Ophthalmic Srl

Casa
Italia
Sandrigo
Resono Ophthalmic Srl

Resono Ophthalmic is an innovative Italian SME founded in 2014 to develop and sell cutting-edge therapeutic devices for Ophthalmology.

Resono Ophthalmic is an Italian company developing therapeutical devices for Ophthalmology based on QMR®, a patented technology that stimulates the natural regeneration of cells. The key feature of our devices is the Quantum Molecular Resonance (QMR®) treatment. It is a patented technology that stimulates the natural regeneration of cells and tissue by delivering low-power, high-frequency electric

al fields. We first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. Clinical trials in Italy and abroad have provided scientific evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR® in stimulating cell and tissue regeneration are currently under investigation also for its possible application in other eye diseases. For more information about technical and clinical details, please visit our website.

*QMR® is a registered trademark by Telea Electronic Engineering.

26/05/2026

Join us for an international clinical discussion dedicated to one of the most relevant questions in modern hashtag management:
“𝗪𝗵𝗮𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝘄𝗲 𝗱𝗼 𝘄𝗵𝗲𝗻 𝗜𝗣𝗟 𝗮𝗹𝗼𝗻𝗲 𝗶𝘀 𝗻𝗼𝘁 𝗲𝗻𝗼𝘂𝗴𝗵?”
Together with Dr. Luca Vigo MD and MSc, MBA Alessandro Pozzato, we will explore the complementary roles of hashtag and hashtag in ocular surface disease management, with practical clinical insights for daily practice.
___
June 10, 18:30 (CEST)
𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄: https://academy.resono.it/

13/05/2026

𝗤𝗠𝗥 𝗧𝗘𝗖𝗛𝗡𝗢𝗟𝗢𝗚𝗬 𝗔𝗗𝗩𝗔𝗡𝗖𝗘𝗦 𝗜𝗡 𝗥𝗘𝗧𝗜𝗡𝗔 𝗥𝗘𝗦𝗘𝗔𝗥𝗖𝗛
QMR technology is now being presented at 𝟮𝟬𝟮𝟲 in Denver, Colorado, with new results focused on the retina.

Following last year’s work on dry AMD, Dr. Sergio Zaccaria Scalinci and his team are now presenting the abstract:
“𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗥𝗲𝘁𝗶𝗻𝗮𝗹 𝗣𝗶𝗴𝗺𝗲𝗻𝘁 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝘂𝗺 𝗺𝗶𝗰𝗿𝗼𝗥𝗡𝗔 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀 𝗯𝘆 𝗤𝗠𝗥 𝗮𝗻𝗱 𝗕𝗹𝗼𝗼𝗱-𝗗𝗲𝗿𝗶𝘃𝗲𝗱 𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 𝗨𝗻𝗱𝗲𝗿 𝗢𝘅𝗶𝗱𝗮𝘁𝗶𝘃𝗲 𝗦𝘁𝗿𝗲𝘀𝘀.”

This marks an important step forward: from clinical exploration in maculopathy to a deeper investigation of retinal pigment epithelium pathways and oxidative stress mechanisms.

12/05/2026

🇫🇷 SFO Congress in Paris
Proud of the dedication and outstanding performance of our partners Ophtalmic Compagnie 👏🏼👏🏼

07/05/2026

𝗤𝗠𝗥 𝗧𝗘𝗖𝗛𝗡𝗢𝗟𝗢𝗚𝗬 𝗔𝗗𝗩𝗔𝗡𝗖𝗘𝗦 𝗜𝗡 𝗥𝗘𝗧𝗜𝗡𝗔 𝗥𝗘𝗦𝗘𝗔𝗥𝗖𝗛
QMR technology is now being presented at ARVO 𝟮𝟬𝟮𝟲 in Denver, Colorado, with new results focused on the retina.

Following last year’s work on dry AMD, Dr. Sergio Zaccaria Scalinci and his team are now presenting the abstract:
“𝗠𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗥𝗲𝘁𝗶𝗻𝗮𝗹 𝗣𝗶𝗴𝗺𝗲𝗻𝘁 𝗘𝗽𝗶𝘁𝗵𝗲𝗹𝗶𝘂𝗺 𝗺𝗶𝗰𝗿𝗼𝗥𝗡𝗔 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀 𝗯𝘆 𝗤𝗠𝗥 𝗮𝗻𝗱 𝗕𝗹𝗼𝗼𝗱-𝗗𝗲𝗿𝗶𝘃𝗲𝗱 𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 𝗨𝗻𝗱𝗲𝗿 𝗢𝘅𝗶𝗱𝗮𝘁𝗶𝘃𝗲 𝗦𝘁𝗿𝗲𝘀𝘀.”

This marks an important step forward: from clinical exploration in maculopathy to a deeper investigation of retinal pigment epithelium pathways and oxidative stress mechanisms.

24/04/2026

Thank you to our UK partners, Hanson Medical, for the warm welcome extended to our Resono Ophthalmic Srl team and for the excellent organization of the Rexon-Eye presentation during the Ocular Surface Insight (OSI) Congress in London.
We are excited about this collaboration and look forward to creating new opportunities together while advancing ocular surface care!

20/04/2026

𝗥𝗲𝘅𝗼𝗻 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻!
We are proud to introduce the next step in the evolution of the Rexon brand, which will be unveiled at the upcoming Congress.

Join us at 𝗕𝗼𝗼𝘁𝗵 𝗔.𝟯𝟬𝟰 to discover our latest developments through engaging presentations and live discussions.

We invite you to book your appointment in advance with our team 👉🏼 𝗰𝗼𝗻𝘁𝗮𝗰𝘁@𝗿𝗲𝘀𝗼𝗻𝗼.𝗶𝘁

17/04/2026

🇦🇷 Proud to see the incredible MED oftalmología representing Rexon-Eye at the CNO26 Congress, organized by Consejo Argentino de Oftalmología.

Expanding access to innovative solutions for treatment through our patented technology, and bringing eye wellness to more professionals and patients!

16/04/2026

𝗥𝗲𝘅𝗼𝗻 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻!

We are proud to introduce the next step in the evolution of the Rexon brand, which will be unveiled at the upcoming The The European Society of Cataract and Refractive Surgeons (ESCRS).

Join us at 𝗕𝗼𝗼𝘁𝗵 𝗔.𝟯𝟬𝟰 to discover our latest developments through engaging presentations and live discussions.

We invite you to book your appointment in advance with our team: 𝗰𝗼𝗻𝘁𝗮𝗰𝘁@𝗿𝗲𝘀𝗼𝗻𝗼.𝗶𝘁

18/02/2026

Rexon-Eye at SITRAC - Expanding the awareness of a comprehensive technology for ophthalmology

With our national partner SIR Oftalmica SRL Rexon-Eye and technology had the pleasure of attending the National Congress of SITRAC - Società Italiana Trapianto di Cornea e Superficie Oculare (Italian Society for Corneal Transplantation and Ocular Surface).
It was a valuable opportunity to share our vision of innovation and to highlight the inclusiveness and broad potential that QMR technology brings to the field of ophthalmology.

A special thank you to the entire SIR team for their commitment, and to Dr. Andrea Bedei for his insightful presentation on our technology.

Get in touch with our partner 👉 https://lnkd.in/g9jvteuX

Indirizzo

Sandrigo

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Sito Web

https://rexoneye.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Resono Ophthalmic Srl pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.